ATTUNE FEMORAL CRUCIATE RETAINING NARROW SIZE 5N RIGHT CEMENTED Femoral Implant ATTUNE CR FEM RT SZ 5 NAR CEM Product number 150400225. Knee prosthesis component. Recall
ATTUNE FEMORAL CRUCIATE RETAINING NARROW SIZE 5N RIGHT CEMENTED Femoral Implant ATTUNE CR FEM RT SZ 5 NAR CEM Product number 150400225. Knee prosthesis component.
FDA recall Class II
Open , Classified
FDA lists this Class II recall for ATTUNE FEMORAL CRUCIATE RETAINING NARROW SIZE 5N RIGHT CEMENTED Femoral Implant ATTUNE CR FEM RT SZ 5 NAR CEM Product number 150400225. Knee prosthesis component.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0522-2027
- Recall classification
- Class II
- FDA database status
- Open , Classified
- Initiation date
- Oct 28, 2026
- FDA website posting date
- Nov 20, 2026
- Quantity in commerce
- 9
- Distribution
- See key details
- FDA cause
- Not reported
What is being recalled?
ATTUNE FEMORAL CRUCIATE RETAINING NARROW SIZE 5N RIGHT CEMENTED Femoral Implant ATTUNE CR FEM RT SZ 5 NAR CEM Product number 150400225. Knee prosthesis component.
The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.
Search FDA identifier text
Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.
This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.
FDA code information
UDI-DI (GTIN) 10603295041283 Lot MN0418
Why was this product recalled?
Size 4 implants incorrectly labeled as Size 5N on the outer boxes. If the issue is detected prior to implantation, it may result in a minor surgical delay. Implantation of an oversized device may lead to bone damage, loosening, or poor joint mechanics.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did DePuy Orthopaedics, Inc. take?
The firm began notifying customers on 10/28/26 via letters titled URGENT MEDICAL DEVICE REMOVAL. Customers were instructed to examine their inventory to determine if they have affected product. Affected product should be quarantined immediately. Do NOT use the subject product lot. Customers should contact their DePuy Synthes Sales Consultant or contact customer support services to coordinate the return/credits of the subject products. Customers should forward the notice to anyone in their facility who needs to be informed, and post a copy of the notice in a visible area for awareness.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0522-2027
- FDA recall database source · Posted Nov 20, 2026 · Retrieved Nov 21, 2026
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology